General Information of Drug (ID: DMDNVJY)

Drug Name
VLA15-101
Indication
Disease Entry ICD 11 Status REF
Lyme disease 1C1G Phase 1 [1]
Cross-matching ID
TTD ID
D01IMN

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)